|
|
Volumn 47 Suppl 3, Issue , 2008, Pages
|
|
Efficacy as an important facet of "safety" in clinical trials: how can we do our best for our patients?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
BACTERIAL PNEUMONIA;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
DRUG TOXICITY;
HUMAN;
REVIEW;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS AS TOPIC;
COMMUNITY-ACQUIRED INFECTIONS;
DRUG TOXICITY;
HUMANS;
PNEUMONIA, BACTERIAL;
TREATMENT OUTCOME;
|
|
EID: 58149231464
PISSN: None
EISSN: 15376591
Source Type: Journal
DOI: 10.1086/591401 Document Type: Review |
|
Times cited : (4)
|
|
References (17)
|
